These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 23402336)

  • 41. Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.
    Nyuyki F; Plotkin M; Graf R; Michel R; Steffen I; Denecke T; Geworski L; Fahdt D; Brenner W; Wurm R
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):310-8. PubMed ID: 19763565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas.
    Vlachogiannis P; Gudjonsson O; Montelius A; Grusell E; Isacsson U; Nilsson K; Blomquist E
    Acta Neurochir (Wien); 2017 Dec; 159(12):2391-2400. PubMed ID: 29064038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
    Wu A; Jin MC; Meola A; Wong HN; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.
    Seystahl K; Stoecklein V; Schüller U; Rushing E; Nicolas G; Schäfer N; Ilhan H; Pangalu A; Weller M; Tonn JC; Sommerauer M; Albert NL
    Neuro Oncol; 2016 Nov; 18(11):1538-1547. PubMed ID: 27106404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons.
    Noël G; Bollet MA; Calugaru V; Feuvret L; Haie-Meder C; Dhermain F; Ferrand R; Boisserie G; Beaudré A; Mazeron JJ; Habrand JL
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1412-22. PubMed ID: 16029801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography.
    Ryttlefors M; Danfors T; Latini F; Montelius A; Blomquist E; Gudjonsson O
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1432-43. PubMed ID: 26819102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas.
    Dittmar JO; Kratochwil C; Dittmar A; Welzel T; Habermehl D; Rieken S; Giesel FL; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2017 Nov; 12(1):169. PubMed ID: 29110720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction in the recurrence of meningiomas by combining somatostatin receptor scintigraphy of (99m)Tc-HYNIC-octreotide SPECT/CT and radio guidance with a hand-held γ-probe during surgery.
    Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
    Nucl Med Commun; 2013 Mar; 34(3):249-53. PubMed ID: 23276828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereotactically guided conformal radiotherapy for meningiomas.
    Alheit H; Saran FH; Warrington AP; Rosenberg I; Perks J; Jalali R; Shepherd S; Beardmore C; Baumert B; Brada M
    Radiother Oncol; 1999 Feb; 50(2):145-50. PubMed ID: 10368037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location.
    Jalali R; Loughrey C; Baumert B; Perks J; Warrington AP; Traish D; Ashley S; Brada M
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):103-9. PubMed ID: 12069116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helical tomotherapy for meningiomas of the skull base and in paraspinal regions with complex anatomy and/or multiple lesions.
    Combs SE; Sterzing F; Uhl M; Habl G; Schubert K; Debus J; Herfarth K
    Tumori; 2011; 97(4):484-91. PubMed ID: 21989438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas.
    Sanford NN; Yeap BY; Larvie M; Daartz J; Munzenrider JE; Liebsch NJ; Fullerton B; Pan E; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):787-796. PubMed ID: 28865924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
    Combs SE; Adeberg S; Dittmar JO; Welzel T; Rieken S; Habermehl D; Huber PE; Debus J
    Radiother Oncol; 2013 Feb; 106(2):186-91. PubMed ID: 22906549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton therapy for atypical meningiomas.
    McDonald MW; Plankenhorn DA; McMullen KP; Henderson MA; Dropcho EJ; Shah MV; Cohen-Gadol AA
    J Neurooncol; 2015 May; 123(1):123-8. PubMed ID: 25859843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas.
    Nathoo N; Ugokwe K; Chang AS; Li L; Ross J; Suh JH; Vogelbaum MA; Barnett GH
    J Neurooncol; 2007 Jan; 81(2):167-74. PubMed ID: 16850106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
    Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
    J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome.
    Kessel KA; Weber W; Yakushev I; Fischer H; Voglhuber T; Diehl C; Straube C; Zimmer C; Wiestler B; Gempt J; Meyer B; Combs SE
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1391-1399. PubMed ID: 31758226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parameters influencing local control of meningiomas treated with radiosurgery.
    Kaprealian T; Raleigh DR; Sneed PK; Nabavizadeh N; Nakamura JL; McDermott MW
    J Neurooncol; 2016 Jun; 128(2):357-64. PubMed ID: 27131883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton stereotactic radiosurgery for the treatment of benign meningiomas.
    Halasz LM; Bussière MR; Dennis ER; Niemierko A; Chapman PH; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1428-35. PubMed ID: 20934263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
    Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.